dermatology paediatrics
SCORAD — SCORing Atopic Dermatitis
European Task Force on Atopic Dermatitis severity index. Total = A/5 + 7B/2 + C, where A = extent (0–100% TBSA), B = sum of 6 intensity items (each 0–3, max 18), C = subjective pruritus + sleep loss VAS (0–20). Pick severity band below — or compute the formula manually.
References
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Baricitinib 2–4mg (Atopic Dermatitis / Alopecia Areata) · JAK inhibitor (JAK1/JAK2) — systemic immunosuppressant
- Tralokinumab · IL-13 Inhibitor — Atopic Eczema
- Abrocitinib · JAK1 Inhibitor — Atopic Eczema
- Lebrikizumab · IL-13 Inhibitor — Atopic Eczema
- Ciclosporin · Systemic Immunosuppressant — Eczema / Psoriasis
- Azathioprine · Systemic Immunosuppressant — Eczema / Autoimmune Dermatoses
Pathways
- Suspicious Pigmented Lesion — Melanoma Pathway · NICE NG14 2015 / BAD
- Cellulitis and Erysipelas · NICE NG141 2019 / CREST
- Psoriasis — Severity Assessment and Step-Up Therapy · NICE NG153 2019 / BAD
- Atopic Eczema — Assessment and Step-Up Therapy · NICE NG95 2023
- Urticaria and Angioedema · BSACI / EAACI Guidelines 2022
- Acne Vulgaris — Grading and Treatment · NICE NG198 2021 / BAD
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.